Literature DB >> 19129496

Rb/Cdk2/Cdk4 triple mutant mice elicit an alternative mechanism for regulation of the G1/S transition.

Weimin Li1, Shuhei Kotoshiba, Cyril Berthet, Mary Beth Hilton, Philipp Kaldis.   

Abstract

The G(1)/S-phase transition is a well-toned switch in the mammalian cell cycle. Cdk2, Cdk4, and the rate-limiting tumor suppressor retinoblastoma protein (Rb) have been studied in separate animal models, but interactions between the kinases and Rb in vivo have yet to be investigated. To further dissect the regulation of the G(1) to S-phase progression, we generated Cdk2(-/-)Cdk4(-/-)Rb(-/-) (TKO) mutant mice. TKO mice died at midgestation with major defects in the circulatory systems and displayed combined phenotypes of Rb(-/-) and Cdk2(-/-)Cdk4(-/-) mutants. However, TKO mouse embryonic fibroblasts were not only resistant to senescence and became immortal but displayed enhanced S-phase entry and proliferation rates similar to wild type. These effects were more remarkable in hypoxic compared with normoxic conditions. Interestingly, depletion of the pocket proteins by HPV-E7 or p107/p130 shRNA in the absence of Cdk2/Cdk4 elicited a mechanism for the G(1)/S regulation with increased levels of p27(Kip1) binding to Cdk1/cyclin E complexes. Our work indicates that the G(1)/S transition can be controlled in different ways depending on the situation, resembling a regulatory network.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19129496      PMCID: PMC2626729          DOI: 10.1073/pnas.0804177106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Mitogen requirement for cell cycle progression in the absence of pocket protein activity.

Authors:  Floris Foijer; Rob M F Wolthuis; Valerie Doodeman; René H Medema; Hein te Riele
Journal:  Cancer Cell       Date:  2005-12       Impact factor: 31.743

Review 2.  Cyclin-dependent kinases: engines, clocks, and microprocessors.

Authors:  D O Morgan
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

3.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

4.  Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

Authors:  K Nakayama; N Ishida; M Shirane; A Inomata; T Inoue; N Shishido; I Horii; D Y Loh; K Nakayama
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

5.  Mouse development and cell proliferation in the absence of D-cyclins.

Authors:  Katarzyna Kozar; Maria A Ciemerych; Vivienne I Rebel; Hirokazu Shigematsu; Agnieszka Zagozdzon; Ewa Sicinska; Yan Geng; Qunyan Yu; Shoumo Bhattacharya; Roderick T Bronson; Koichi Akashi; Piotr Sicinski
Journal:  Cell       Date:  2004-08-20       Impact factor: 41.582

6.  Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry.

Authors:  Julien Sage; Abigail L Miller; Pedro A Pérez-Mancera; Julianne M Wysocki; Tyler Jacks
Journal:  Nature       Date:  2003-07-10       Impact factor: 49.962

Review 7.  Human papillomavirus immortalization and transformation functions.

Authors:  Karl Münger; Peter M Howley
Journal:  Virus Res       Date:  2002-11       Impact factor: 3.303

8.  Shared role of the pRB-related p130 and p107 proteins in limb development.

Authors:  D Cobrinik; M H Lee; G Hannon; G Mulligan; R T Bronson; N Dyson; E Harlow; D Beach; R A Weinberg; T Jacks
Journal:  Genes Dev       Date:  1996-07-01       Impact factor: 11.361

9.  Targeted disruption of p107: functional overlap between p107 and Rb.

Authors:  M H Lee; B O Williams; G Mulligan; S Mukai; R T Bronson; N Dyson; E Harlow; T Jacks
Journal:  Genes Dev       Date:  1996-07-01       Impact factor: 11.361

10.  Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene.

Authors:  J E LeCouter; B Kablar; P F Whyte; C Ying; M A Rudnicki
Journal:  Development       Date:  1998-12       Impact factor: 6.868

View more
  15 in total

1.  Nuclear translocation of PKM2 modulates astrocyte proliferation via p27 and -catenin pathway after spinal cord injury.

Authors:  Jinlong Zhang; Guijuan Feng; Guofeng Bao; Guanhua Xu; Yuyu Sun; Weidong Li; Lingling Wang; Jiajia Chen; Huricha Jin; Zhiming Cui
Journal:  Cell Cycle       Date:  2015-07-07       Impact factor: 4.534

2.  Star-PAP controls HPV E6 regulation of p53 and sensitizes cells to VP-16.

Authors:  W Li; R A Anderson
Journal:  Oncogene       Date:  2013-02-18       Impact factor: 9.867

3.  Activation of NFAT signaling establishes a tumorigenic microenvironment through cell autonomous and non-cell autonomous mechanisms.

Authors:  P Tripathi; Y Wang; M Coussens; K R Manda; A M Casey; C Lin; E Poyo; J D Pfeifer; N Basappa; C M Bates; L Ma; H Zhang; M Pan; L Ding; F Chen
Journal:  Oncogene       Date:  2013-04-29       Impact factor: 9.867

Review 4.  Cdc2: a monopotent or pluripotent CDK?

Authors:  X Hu; L C Moscinski
Journal:  Cell Prolif       Date:  2011-06       Impact factor: 6.831

5.  Hematopoiesis specific loss of Cdk2 and Cdk4 results in increased erythrocyte size and delayed platelet recovery following stress.

Authors:  Senthil Raja Jayapal; Chelsia Qiuxia Wang; Xavier Bisteau; Matias J Caldez; Shuhui Lim; Vinay Tergaonkar; Motomi Osato; Philipp Kaldis
Journal:  Haematologica       Date:  2015-01-23       Impact factor: 9.941

6.  Sequential inductions of the ZEB1 transcription factor caused by mutation of Rb and then Ras proteins are required for tumor initiation and progression.

Authors:  Yongqing Liu; Ester Sánchez-Tilló; Xiaoqin Lu; Li Huang; Brian Clem; Sucheta Telang; Alfred B Jenson; Miriam Cuatrecasas; Jason Chesney; Antonio Postigo; Douglas C Dean
Journal:  J Biol Chem       Date:  2013-02-26       Impact factor: 5.157

7.  Cdk2 catalytic activity is essential for meiotic cell division in vivo.

Authors:  Sangeeta Chauhan; M Kasim Diril; Joanna H S Lee; Xavier Bisteau; Vanessa Manoharan; Deepak Adhikari; Chandrahas Koumar Ratnacaram; Baptiste Janela; Juliane Noffke; Florent Ginhoux; Vincenzo Coppola; Kui Liu; Lino Tessarollo; Philipp Kaldis
Journal:  Biochem J       Date:  2016-07-01       Impact factor: 3.857

8.  Genetic mouse models to investigate cell cycle regulation.

Authors:  Weimin Li; Shuhei Kotoshiba; Philipp Kaldis
Journal:  Transgenic Res       Date:  2009-05-06       Impact factor: 2.788

9.  Cdk2 and Cdk4 activities are dispensable for tumorigenesis caused by the loss of p53.

Authors:  V C Padmakumar; Eiman Aleem; Cyril Berthet; Mary Beth Hilton; Philipp Kaldis
Journal:  Mol Cell Biol       Date:  2009-03-23       Impact factor: 4.272

10.  B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation.

Authors:  Cinzia Giagulli; Francesca Caccuri; Simone Zorzan; Antonella Bugatti; Alberto Zani; Federica Filippini; Ekta Manocha; Pasqualina D'Ursi; Alessandro Orro; Riccardo Dolcetti; Arnaldo Caruso
Journal:  Cancer Gene Ther       Date:  2020-10-22       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.